Liquid Chromatographic Analysis of 9-Aminocamptothecin in Plasma Monitored by Fluorescence Induced upon Postcolumn Acidification
- 1 December 1992
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 15 (18) , 3261-3283
- https://doi.org/10.1080/10826079208020883
Abstract
Through preclinical studies by the Developmental Therapeutics Program of the National Cancer Institute with 9-amino-20(S)-camptothecin (AC), this new investigational anticancer agent will soon enter phase I clinical trials in cancer patients. During initial attempts to monitor the drug in biological fluids, it became evident that the presence of an amino group on the camptothecin A-ring suppressed the intense native fluorescence characteristic of the unsubstituted compound. However, subsequent spectro-fluorometric studies revealed that the fluorescence of AC was highly pH-dependent in a manner not typically exhibited by aromatic amines. The uncharged species that exists in neutral and weakly acidic solution is nonfiuorescent. Protonation of the C-9 amino group proceeds with the development of fluorescence, the intensity of which is optimum in moderately acidic solution of apparent pH 1.7-2.3. Under more strongly acidic conditions, fluorescent intensity again diminishes due to further protonation at the quinoline nitrogen atom. Therefore, postcolumn acidification prior to fluorescence detection provided a convenient and sensitive method to monitor the elution of AC during liquid chromatography. Following protein precipitation induced by mixing with a solution of the internal standard, camptothecin, in methanol chilled to -70 °C, plasma samples were separated on a 5 μm Ultrasphere ODS column (4.6 mm × 25 cm) using an isocratic mobiie phase composed of acetonuliie-methanoi-0.1 M ammonium acetate buffer, pH 5 5 (23: 0:67, v/v/v) at a flow rate of 1.0 ml min. Prior to detection, the column effluent was mixed inline with 0.3 M aqueous trifluoroacetic acid at a flow rate of 0.3 ml/min and ambient temperature. Fluorescence was then monitored using an excitation wavelength of 352 nm and a 418 nm emission cutoff filter. Typical retention times of the drug and internal standard were 7 and 12 min, respectively. Employing sample volumes of 50 μl, the lowest plasma concentration of AC included in the standard curve, 13.3 nM (5.0 ng/ml) was quantified with a 7.63% coefficient of variation (n = 10).Keywords
This publication has 10 references indexed in Scilit:
- Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.Published by Elsevier ,2021
- A Reversed-Phase HPLC Method For Determining Camptothecin In Plasma With Specificity For the Intact Lactone Form of the DrugJournal of Liquid Chromatography, 1991
- Plant antitumor agents. 25. Total synthesis and antileukemic activity of ring A substituted camptothecin analogs. Structure-activity correlationsJournal of Medicinal Chemistry, 1987
- Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogsJournal of Medicinal Chemistry, 1986
- Plant antitumor agents. 22. Isolation of 11-hydroxycamptothecin from Camptotheca acuminata decne: total synthesis and biological activityJournal of Medicinal Chemistry, 1986
- Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogsJournal of Medicinal Chemistry, 1980
- Prodrug analogs of the antitumor alkaloid camptothecinJournal of Medicinal Chemistry, 1979
- Experiments on the synthesis of dl-camptothecin. 4. Synthesis and antileukemic activity of dl-camptothecin analoguesJournal of Medicinal Chemistry, 1976
- Antineoplastic Principles in Plants: Recent Developments in the FieldPublished by Elsevier ,1970
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966